Literature DB >> 4975014

CSF immunoglobulins in multiple sclerosis and other neurologic diseases. Measurement by electroimmunodiffusion.

S A Schneck, H N Claman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4975014     DOI: 10.1001/archneur.1969.00480080032003

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  8 in total

1.  Intrathecal IgG synthesis in multiple sclerosis and other neurological diseases: a comparative evaluation by IgG-index and isoelectric focusing.

Authors:  M Poloni; B Rocchelli; R Scelsi; P Pinelli
Journal:  J Neurol       Date:  1979-10       Impact factor: 4.849

2.  The alpha2-macroglobulin level in cerebrospinal fluid; a parameter for the condition of the blood-CSF barrier.

Authors:  G Schliep; K Felgenhauer
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

3.  Serum IgG, IgA and IgM concentration in 1,038 patients with various neurological disorders.

Authors:  O J Kolar; A T Ross; H Gilliam
Journal:  Z Neurol       Date:  1972

4.  Immunoglobulin levels in the cerebrospinal fluid.

Authors:  D Riddoch; R A Thompson
Journal:  Br Med J       Date:  1970-02-14

5.  Double ring formation in single radial immunodiffusion for kappa chains in multiple sclerosis cerebrospinal fluid.

Authors:  H Iwashita; F Grunwald; H Bauer
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

6.  Idiopathic inflammatory polyradiculoneuropathy: evaluation of clinical and laboratory data and therapeutic considerations.

Authors:  G Valli; L Ferini Strambi; E Nobile Orazio; G Scarlato
Journal:  Ital J Neurol Sci       Date:  1983-04

7.  Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease.

Authors:  P J Roberts-Thomson; M M Esiri; A C Young; I C Maclennan
Journal:  J Clin Pathol       Date:  1976-12       Impact factor: 3.411

8.  Multiple sclerosis associated with defects in neuromuscular transmission.

Authors:  B M Patten; A Hart; R Lovelace
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-06       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.